Living Cell Technologies Clinical Trial Proves Positive For All The Type 1 Diabetes Patients
Thursday, July 24th, 2008Living Cell Technologies Limited has today released the results of their DiabeCell(R) trials on Six patients with insulin dependent (type 1) diabetes. The company has released the results describing clinical benefit of the Company’s encapsulated porcine islet cells for the treatment of type 1 diabetes.
































